These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29279284)

  • 1. Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged ≥5 years after 13-valent pneumococcal conjugate vaccine introduction-Alaska, 2008-2013.
    Gounder PP; Bruden D; Rudolph K; Zulz T; Hurlburt D; Thompson G; Bruce MG; Hennessy TW
    Vaccine; 2018 Jan; 36(5):691-697. PubMed ID: 29279284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.
    McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC
    Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012.
    Gounder PP; Bruce MG; Bruden DJ; Singleton RJ; Rudolph K; Hurlburt DA; Hennessy TW; Wenger J
    J Infect Dis; 2014 Apr; 209(8):1251-8. PubMed ID: 24273178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Pneumococcal Conjugate Vaccine and Antibiotic Use on Nasopharyngeal Colonization by Antibiotic Nonsusceptible Streptococcus pneumoniae, Alaska, 2000[FIGURE DASH]2010.
    Gounder PP; Brewster M; Bruce MG; Bruden DJ; Rudolph K; Hurlburt DA; Hennessy TW
    Pediatr Infect Dis J; 2015 Nov; 34(11):1223-9. PubMed ID: 26226443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia.
    Rockett RJ; Oftadeh S; Bachmann NL; Timms VJ; Kong F; Gilbert GL; Sintchenko V
    Sci Rep; 2018 Nov; 8(1):16969. PubMed ID: 30446692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of private use of PCV7 in 2009 and 2010 on serotypes and antimicrobial resistance of Streptococcus pneumoniae carried by young children in Portugal: Comparison with data obtained since 1996 generating a 15-year study prior to PCV13 introduction.
    Nunes S; Félix S; Valente C; Simões AS; Tavares DA; Almeida ST; Paulo AC; Brito-Avô A; de Lencastre H; Sá-Leão R
    Vaccine; 2016 Mar; 34(14):1648-56. PubMed ID: 26920470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel.
    Rokney A; Ben-Shimol S; Korenman Z; Porat N; Gorodnitzky Z; Givon-Lavi N; Ron M; Agmon V; Dagan R; Valinsky L
    Emerg Infect Dis; 2018 Mar; 24(3):453-461. PubMed ID: 29460732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska.
    Bruce MG; Singleton R; Bulkow L; Rudolph K; Zulz T; Gounder P; Hurlburt D; Bruden D; Hennessy T
    Vaccine; 2015 Sep; 33(38):4813-9. PubMed ID: 26247901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
    Nzenze SA; Madhi SA; Shiri T; Klugman KP; de Gouveia L; Moore DP; Karstaedt AS; Tempia S; Nunes MC; von Gottberg A
    Am J Epidemiol; 2017 Aug; 186(4):435-444. PubMed ID: 28482004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014.
    Ceyhan M; Ozsurekci Y; Gürler N; Öksüz L; Aydemir S; Ozkan S; Yuksekkaya S; Keser Emiroglu M; Gültekin M; Yaman A; Kiremitci A; Yanık K; Karli A; Ozcinar H; Aydin F; Bayramoglu G; Zer Y; Gulay Z; Gayyurhan ED; Gül M; Özakın C; Güdücüoğlu H; Perçin D; Akpolat N; Ozturk C; Camcıoğlu Y; Karadağ Öncel E; Çelik M; Şanal L; Uslu H
    Hum Vaccin Immunother; 2016; 12(2):308-13. PubMed ID: 26325175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa.
    Nzenze SA; von Gottberg A; Shiri T; van Niekerk N; de Gouveia L; Violari A; Nunes MC; Madhi SA
    J Infect Dis; 2015 Oct; 212(7):1082-92. PubMed ID: 25784729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M
    Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.
    Dagan R
    Expert Rev Vaccines; 2019 Jun; 18(6):641-661. PubMed ID: 31230486
    [No Abstract]   [Full Text] [Related]  

  • 15. Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: A population-based cross-sectional study in South Western Uganda, 2014.
    Nackers F; Cohuet S; le Polain de Waroux O; Langendorf C; Nyehangane D; Ndazima D; Nanjebe D; Karani A; Tumwesigye E; Mwanga-Amumpaire J; Scott JAG; Grais RF
    Vaccine; 2017 Sep; 35(39):5271-5277. PubMed ID: 28784282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013.
    Miernyk KM; Bulkow LR; Case SL; Zulz T; Bruce MG; Harker-Jones M; Hurlburt DA; Hennessy TW; Rudolph KM
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):224-30. PubMed ID: 27498610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
    Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
    Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine.
    Wei SH; Chiang CS; Chiu CH; Chou P; Lin TY
    Pediatr Infect Dis J; 2015 Mar; 34(3):e71-7. PubMed ID: 25247584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.
    Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA
    Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.